ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 1 filers reported holding ARGOS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $96,000 | -20.0% | 643,265 | -3.4% | 0.00% | -50.0% |
Q3 2017 | $120,000 | +41.2% | 665,831 | +256.2% | 0.00% | +100.0% |
Q1 2017 | $85,000 | -99.5% | 186,900 | -94.3% | 0.00% | -99.6% |
Q4 2016 | $15,946,000 | -0.6% | 3,254,211 | +0.8% | 0.24% | +0.8% |
Q3 2016 | $16,047,000 | +10.2% | 3,228,741 | +35.2% | 0.24% | +7.2% |
Q2 2016 | $14,559,000 | -23.0% | 2,388,481 | -0.8% | 0.22% | -22.8% |
Q1 2016 | $18,899,000 | +259.4% | 2,407,333 | +5.8% | 0.29% | +301.4% |
Q4 2015 | $5,258,000 | -52.8% | 2,276,199 | -1.0% | 0.07% | -51.7% |
Q3 2015 | $11,149,000 | -24.1% | 2,298,711 | +7.3% | 0.15% | -6.9% |
Q2 2015 | $14,680,000 | -24.1% | 2,143,043 | -1.3% | 0.16% | -20.4% |
Q1 2015 | $19,349,000 | +32.9% | 2,171,633 | +49.2% | 0.20% | +33.1% |
Q4 2014 | $14,557,000 | +24.9% | 1,455,720 | +25.7% | 0.15% | +23.8% |
Q3 2014 | $11,653,000 | +16.8% | 1,158,344 | -6.8% | 0.12% | +25.8% |
Q2 2014 | $9,975,000 | -19.4% | 1,242,194 | +0.4% | 0.10% | -19.2% |
Q1 2014 | $12,374,000 | – | 1,237,427 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pharmstandard International S.A. | 13,242,279 | $2,377,000 | 6.93% |
Pharmstandard International S.A. | 5,120,604 | $919,000 | 2.68% |
SANDERS MORRIS HARRIS LLC | 132,212 | $23,000 | 0.01% |
WEDBUSH SECURITIES INC | 112,000 | $20,000 | 0.00% |
WASATCH ADVISORS LP | 665,831 | $120,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 149,999 | $27,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 129,046 | $23,000 | 0.00% |
STATE STREET CORP | 11,900 | $2,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 180,032 | $32,000 | 0.00% |
GUGGENHEIM CAPITAL LLC | 27,984 | $5,000 | 0.00% |